Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00872885 · ClinicalTrials.gov registry record · Phase 2
Bunionectomy Trial With GRT6005
A Phase 2 study, sponsored by Tris Pharma.
- Completed
- Registry status
- Phase 2
- Development phase
- 258
- Enrollment target
NCT00872885 is a Phase 2 study that has completed, run by Tris Pharma. The registered enrollment target is 258 participants.
The verdict
NCT00872885, a Phase 2 study, has completed, sponsored by Tris Pharma.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 258 participants
- Enrollment target
Study Summary
The purpose of the trial is to determine whether the new centrally acting analgesic is effective in comparison to placebo and an active comparator (morphine).
Interventions
- DRUG Placebo
- DRUG Morphine
- DRUG GRT6005
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 258 participants |
| Start Date | 2009-03 |
| Est. Completion | 2009-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00872885
The ClinicalTrials.gov registry entry for NCT00872885 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 258 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tris Pharma, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00872885 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00872885 about?
NCT00872885 is a clinical study titled "Bunionectomy Trial With GRT6005". The purpose of the trial is to determine whether the new centrally acting analgesic is effective in comparison to placebo and an active comparator (morphine).
What is the current status of trial NCT00872885?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 258 participants. The study started on 2009-03. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00872885?
The interventions under investigation include: Placebo (DRUG), Morphine (DRUG), GRT6005 (DRUG).
Who is sponsoring clinical trial NCT00872885?
This trial is sponsored by Tris Pharma, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.